Greenstone Recalls Nifedipine Tablets Due to Incorrect Expiration Date Labeling
Greenstone LLC is recalling Nifedipine extended-release tablets because the package displays a 48-month expiration date instead of the correct 36-month date.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a minor labeling error regarding the expiration date, which fits the rubric for moderate severity.
Plain-English summary
Greenstone LLC is recalling Nifedipine extended-release tablets, 90mg, 100-count blister packs. The recall is due to a labeling error where the expiration date on the package is listed as 48 months instead of the correct 36 months.
The affected product is distributed nationwide. The specific lot code is V110079. The recall involves 21,600 tablets.
Consumers should check their medication packaging for the NDC 59762-6692-8 and lot code V110079. If the expiration date is listed as 48 months, they should stop using the product and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- Nifedipine, extended-release tablets, 90mg 100 count blister pack, Rx only, Distributed by: GREENSTONE LLC, Pespack, NJ,07977, NDC 59762-6692-8
- Manufacturer
- Greenstone Llc
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 21,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- V110079
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Greenstone Llc
See all →- HighMethylprednisolone dose packs recalled over misoriented blister foil dosing information
FDA (Drugs) · 2026-02-04
- CriticalGreenstone Recalls Venlafaxine Capsules Due to Foreign Capsule Contamination
FDA (Drugs) · 2014-06-18
- LowGreenstone Recalls Glipizide XL Tablets Due to Dissolution Failure
FDA (Drugs) · 2014-02-12
- ModerateGreenstone Recalls Sertraline Tablets Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2014-01-29
- ModerateGreenstone Recalls Spironolactone Tablets Due to Unapproved Manufacturing Site Change
FDA (Drugs) · 2013-11-27
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
Similar recalls
- LowGreenstone Recalls Glipizide XL Tablets Due to Dissolution Failure
FDA (Drugs) · 2014-02-12
- ModerateGreenstone Recalls Sertraline Tablets Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2014-01-29
- LowPfizer Recalls Ethosuximide Capsules Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2019-10-02
- ModeratePfizer Recalls Glipizide XL Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-17
- ModerateGreenstone Recalls Spironolactone Tablets Due to Unapproved Manufacturing Site Change
FDA (Drugs) · 2013-11-27
- ModerateAidapak Recalls Gabapentin Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-29